留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

磁共振成像在可切除性食管癌术前T分期中的应用

王昭琦 郭佳 鲁亚南 张宏凯 黎海亮 曲金荣

王昭琦, 郭佳, 鲁亚南, 张宏凯, 黎海亮, 曲金荣. 磁共振成像在可切除性食管癌术前T分期中的应用[J]. 协和医学杂志, 2017, 8(2-3): 112-116. doi: 10.3969/j.issn.1674-9081.2017.03.006
引用本文: 王昭琦, 郭佳, 鲁亚南, 张宏凯, 黎海亮, 曲金荣. 磁共振成像在可切除性食管癌术前T分期中的应用[J]. 协和医学杂志, 2017, 8(2-3): 112-116. doi: 10.3969/j.issn.1674-9081.2017.03.006
Zhao-qi WANG, Jia GUO, Ya-nan LU, Hong-kai ZHANG, Hai-liang LI, Jin-rong QU. Application of Magnetic Resonance Imaging in the Preoperative T Staging Evaluation of Resectable Esophageal Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 112-116. doi: 10.3969/j.issn.1674-9081.2017.03.006
Citation: Zhao-qi WANG, Jia GUO, Ya-nan LU, Hong-kai ZHANG, Hai-liang LI, Jin-rong QU. Application of Magnetic Resonance Imaging in the Preoperative T Staging Evaluation of Resectable Esophageal Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 112-116. doi: 10.3969/j.issn.1674-9081.2017.03.006

磁共振成像在可切除性食管癌术前T分期中的应用

doi: 10.3969/j.issn.1674-9081.2017.03.006
详细信息
    通讯作者:

    曲金荣  电话:0371-65587595, E-mail:qjryq@126.com

  • 中图分类号: R445.2

Application of Magnetic Resonance Imaging in the Preoperative T Staging Evaluation of Resectable Esophageal Cancer

More Information
    Corresponding author: QU Jin-rong  Tel: 0371-65587595, Email:qjryq@126.com
  • 摘要:

    食管癌的发病率在全球恶性肿瘤中居第8位, 具有较高的死亡率, 主要原因是难以早期诊断及精准分期。目前常用的影像术前分期手段已不能满足临床实际需要, 故磁共振成像(magnetic resonance imaging, MRI)中的扩散加权成像-体素内不相干运动(diffusion weighted imaging-intravoxel incoherent motion, DWI-IVIM)、T2-mapping、radial-VIBE、T2-TSE-BLADE等新技术、新序列在可切除性食管癌术前分期中具有很大优势。

  • 图  1  BLADE序列脉冲示意图:K空间中多组数据带以一定角度连续旋转360度,中央每个数据带均重复采集,边缘区域只有单个数据带覆盖

    图  2  radial-VIBE序列脉冲示意图:利用K空间放射状填充方式,可以获得具有相对高密度的K空间中心填充和相对低密度的外周K空间填充,并且对不同运动状态可以从K空间自动识别,从而重建成不同运动时相对应的T1加权图像

  • [1] Cancer Research UK. Oesophageal cancer incidence statistics[EB/OL]. 2016-01-25.http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/oesophageal-cancer/incidence
    [2] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65:87-108. doi:  10.3322/caac.21262
    [3] Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus:five-year survival of a randomized clinical trial[J]. Ann Surg, 2007, 246:992-1000; discussion 1000-1001. 10.1097/SLA.0b013e31815c4037
    [4] Allum WH, Blazeby JM, Griffin SM, et al. Guidelines for the management of oesophageal and gastric cancer[J]. Gut, 2011, 60:1449-1472. doi:  10.1136/gut.2010.228254
    [5] Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma:a meta-analysis[J]. Lancet Oncol, 2007, 8:226-234. doi:  10.1016/S1470-2045(07)70039-6
    [6] Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma:an updated meta-analysis[J]. Lancet Oncol, 2011, 12:681-692. doi:  10.1016/S1470-2045(11)70142-5
    [7] van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med, 2012, 366:2074-2084. doi:  10.1056/NEJMoa1112088
    [8] Lei J, Han Q, Zhu S, et al. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging[J]. Oncol Lett, 2015, 10:3607-3612. doi:  10.3892/ol.2015.3779
    [9] Godoy MC, Bruzzi JF, Viswanathan C, et al.Multimodality imaging evaluation of esophageal cancer:staging, therapy assessment, and complications[J].Abdom Imaging, 2013, 38:974-993 doi:  10.1007/s00261-013-9986-7
    [10] Algebally AM, Money N, Szmigielski W, et al. The value ofhigh-resolution MRI techniquein patients with rectal carcinoma:pre-operative assessment of mesorectal fascia involvement, circumferential resection margin and local staging[J]. Pol J Radiol, 2015, 80:115-121. doi:  10.12659/PJR.892583
    [11] 唐娜, 尚乃舰, 张红霞, 等.MRI对直肠癌术前T分期的诊断价值[J].实用放射学杂志, 2013, 29:583-585, 597. doi:  10.3969/j.issn.1002-1671.2013.04.019
    [12] 陈伟, 周胜利.磁共振弥散加权成像结合常规序列在食管癌显示及术前分期中的应用[J].中华消化病与影像杂志(电子版), 2014, 04:166-170. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhxhbyyxzz201404004
    [13] 雷益, 邱德正, 翁准, 等.食管癌手术可切除性的MRI评估.放射学实践[J].2005, 20:711-713. doi:  10.3969/j.issn.1000-0313.2005.08.016
    [14] Pech O, Gunter E, Dusemund F, et al. Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer:results from a referral center for early esophageal cancer[J]. Endoscopy, 2010, 42:456-461. doi:  10.1055/s-0029-1244022
    [15] Wu LF, Wang BZ, Feng JL, et al. Preoperative TN staging of esophageal cancer:comparison of miniprobe ultrasonography, spiral CT and MRI[J]. World J Gastroenterol, 2003, 9:219-224. doi:  10.3748/wjg.v9.i2.219
    [16] Quint LE, Glazer GM, Orringer MB. Esophageal imaging by MR and CT:study of normal anatomy and neoplasms[J]. Radiology, 1985, 156:727-731. doi:  10.1148/radiology.156.3.4023234
    [17] Dave UR, Williams AD, Wilson JA, et al. Esophageal can-cer staging with endoscopic MR imaging:pilot study[J]. Radiology, 2004, 230:281-286. doi:  10.1148/radiol.2301021047
    [18] Yamada I, Hikishima K, Miyasaka N, et al. Esophageal carcinoma:Evaluation with q-space diffusion-weighted MR imaging ex vivo[J]. Magn Reson Med, 2015, 73:2262-2273. doi:  10.1002/mrm.25334
    [19] Yamada I, Hikishima K, Miyasaka N, et al. Diffusion-tensor MRI and tractography of the esophageal wall ex vivo[J]. J Magn Reson Imaging, 2014, 40:567-576. doi:  10.1002/jmri.24411
    [20] Yamada I, Miyasaka N, Hikishima K, et al. Ultra-high-resolution MR imaging of esophageal carcinoma at ultra-high field strength (7.0T) ex vivo:correlation with histopathologic findings[J]. Magn Reson Imaging, 2015, 33:413-419. doi:  10.1016/j.mri.2014.11.005
    [21] Wei Y, Wu S, Shi D, et al. Oesophageal carcinoma:comparison of ex vivo high-resolution 3.0 T MR imaging with histopathological findings[J]. Sci Rep, 2016, 6:35109. doi:  10.1038/srep35109
    [22] Wei Y, Wu S, Gao F, et al. Esophageal carcinoma:Ex vivo evaluation by high-spatial-resolution T2-mapping MRI compared with histopathological findings at 3.0T[J]. J Magn Reson Imaging, 2016.doi: 10.1002/jmri.25509.[Epub ahead of print]
    [23] 魏毅, 务森, 朱绍成, 等. 3.0 T MR高分辨率成像对食管癌侵犯食管黏膜固有层至肌层肿瘤分期诊断的价值[J].中华放射学杂志, 2016, 11:852-855. doi:  10.3760/cma.j.issn.1005-1201.2016.11.010
    [24] Giganti F, Ambrosi A, Petrone MC, et al. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer:results from a pilot study[J]. Br J Radiol, 2016, 89:20160087. doi:  10.1259/bjr.20160087
    [25] Riddell AM, Allum WH, Thompson JN, et al. The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathologicalcorrelation[J]. Eur Radiol, 2007, 17:391-399. doi:  10.1007/s00330-006-0363-6
    [26] 翁得河. BLADE刀锋技术详解[J].磁共振成像, 2010, 01:376-379. doi:  10.3969/j.issn.1674-8034.2010.05.013
    [27] 梁汉欢, 梁菊香, 陈华栋. BLADE和SSTSE T2WI在头部MR成像中的价值[J].中国现代医生, 2009, 47:105-106. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zwkjzlml-yyws200923064
    [28] Azevedo RM, de Campos RO, Ramalho M, et al. Free-breathing 3D T1-weighted gradient-echo sequence with radial data sampling in abdominal MRI:preliminary observations[J]. Am J Roentgenol, 2011, 197:650-657. doi:  10.2214/AJR.10.5881
    [29] Chandarana H, Feng L, Block TK, et al. Free-breathing contrast-enhanced multiphase MRI of the liver using a combination of compressed sensing, parallel imaging, and golden-angle radial sampling[J]. Invest Radiol, 2013, 48:10-16. doi:  10.1097/RLI.0b013e318271869c
    [30] Zhang L, Tian C, Wang P, et al. Comparative study of image quality between axial T2-weighted BLADE and turbo spin-echo MRI of the upper abdomen on 3.0 T[J]. Jpn J Radiol, 2015, 33:585-590. doi:  10.1007/s11604-015-0463-9
    [31] 张风光, 张宏凯, 李祥, 等.伪影校正技术联合自由呼吸放射状K空间填充方式的容积内插体部检查对可切除性食管癌术前T分期的价值[J].中华放射学杂志, 2017, 51:114-118. doi:  10.3760/cma.j.issn.1005-1201.2017.02.007
    [32] Zhang F, Qu J, Zhang H, et al.Preoperative T staging of potentially resectable esophageal cancer:a comparison between free-breathing radial VIBE and breath-hold cartesian VIBE, with histopathological correlation[J].Transl Oncol, 2017, 10:324-331. doi:  10.1016/j.tranon.2017.02.006
    [33] 王昭琦, 张风光, 郭佳, 等.高场MRI对可切除性食管癌术前T分期的可行性研究[J].中华医学杂志, 2017, 97:843-846. doi:  10.3760/cma.j.issn.0376-2491.2017.11.010
  • 加载中
图(2)
计量
  • 文章访问数:  240
  • HTML全文浏览量:  36
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-04-25
  • 刊出日期:  2020-10-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!